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Background
autosomal dominant disorder characterized by

Symptoms
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Case presentation (cont.) and evaluation
Loose stools

elevated baseline tryptase (8 ng/ml or greater)
and increased copies of α-tryptase alleles
• Occurs in 3% of the population and more
common in female patients

Case presentation
• A full term, 13-month-old female patient
presented to clinic for an elevated tryptase
• Past medical history: gastroesophageal
reflux disease
• Past surgical history: none
• Family history: older sister with history
of flushing. She eventually had a negative
evaluation for mastocytosis
• Medications: none
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Presentation

• Hereditary Alpha Tryptasemia (HαT) is
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Worsening
Symptoms
fussiness, return controlled
of loose stools,
first episode of
facial flushing

Management

• Diagnosis is made based on symptoms, serum tryptase level,
and genetic testing
• Treatment is supportive in nature and includes maximally
tolerated H1 and H2 histamine blockers as well as cromolyn
for gastrointestinal symptoms
• In patients with HαT and known hypersensitivity, epinephrine
autoinjector is recommended.
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Conclusion
• Given a higher prevalence than systematic mastocytosis, one

Other labs

Attempted
treatment

CBC with
thrombocytosis
and eosinophilia
and peripheral
blood c-kit
D816V negative
Cetirizine as
needed +
epinephrine
autoinjector

CBC normalized Sent microarray Microarray
for copy number showed extra
variants of
allelic alphaTPSAB1, TPSB2, tryptase at

TSPG1, TPSD1

Added cromolyn Cromolyn
dose adjusted
due to side
effects

TPSAB1

Continue
cetirizine and
cromolyn

must have a high degree of suspicion for HαT to include in one’s
differential diagnoses
• Number of allelic copies of alpha tryptase correlates with
symptom severity
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